Advanced search
Publication Cover
OncoImmunology Volume 13, 2024 - Issue 1
Submit an article Journal homepage
542
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade

Anne Hansen Reea Department of Oncology, Akershus University Hospital, Lørenskog, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, NorwayCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8264-3223View further author information
ORCID Icon,
Eirik Høyeb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;c Department of Tumor Biology, Oslo University Hospital, Oslo, NorwayView further author information
,
Ying Esbensenb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;d Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, NorwayView further author information
,
Ann-Christin R. Beitnese Department of Pathology, Akershus University Hospital, Lørenskog, NorwayView further author information
,
Anne Negårdb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;f Department of Radiology, Akershus University Hospital, Lørenskog, NorwayView further author information
,
Linn Bernklevb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;g Department of Gastroenterology, Akershus University Hospital, Lørenskog, NorwayView further author information
,
Linn Kruse Tetlieh Department of Oncology, Sørlandet Hospital, Kristiansand, NorwayView further author information
,
Åsmund A. Fretlandi The Intervention Centre and Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, NorwayView further author information
,
Hanne M. Hamrea Department of Oncology, Akershus University Hospital, Lørenskog, NorwayView further author information
,
Christian Kerstena Department of Oncology, Akershus University Hospital, Lørenskog, Norway;j Department of Research, Sørlandet Hospital, Kristiansand, NorwayView further author information
,
Eva Hofslik Department of Oncology, St. Olav’s Hospital, Trondheim, Norway;l Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, NorwayView further author information
,
Marianne G. Gurenb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;m Department of Oncology, Oslo University Hospital, Oslo, NorwayView further author information
,
Halfdan Sorbyen Department of Oncology, Haukeland University Hospital, Bergen, Norway;o Department of Clinical Science, University of Bergen, Bergen, NorwayView further author information
,
Hilde L. Nilsenb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;d Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway;p Department of Microbiology, Oslo University Hospital, Oslo, NorwayView further author information
,
Kjersti Flatmarkb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;c Department of Tumor Biology, Oslo University Hospital, Oslo, Norway;q Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, NorwayView further author information
&
Sebastian Meltzera Department of Oncology, Akershus University Hospital, Lørenskog, NorwayView further author information
 show all
Article: 2372886 | Received 28 Mar 2024, Accepted 22 Jun 2024, Published online: 28 Jun 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.